Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Cyxone logo — Life-changing treatments for disorders of the immune system

Cyxone

Life-changing treatments for disorders of the immune system

Founded 2015 Sweden Sweden 11 employees Biotechnology, Health Care

General Information

Company Name Cyxone
Founded Year 2015
Location Sweden Sweden
Employees 11
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Cyxone. To contact Cyxone, visit cyxone.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cyxone compare?

A PDF of Cyxone and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cyxone soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cyxone

Cyxone is a Swedish clinical biotech company that focuses on developing immunomodulating drugs for treating autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The company's portfolio includes rabeximod, currently in a clinical phase II program for RA, and T20K, which has completed a phase I infusion study for MS. Cyxone aims to address the unmet need for new, effective, and safe medicines to enhance the quality of life for patients with autoimmune diseases. Founded in 2015, the company operates in the biotechnology and health care industries, with its headquarters in Sweden. Despite the absence of recent disclosed investments and investors, Cyxone's focus on addressing autoimmune diseases through innovative drugs positions it as a potential opportunity for venture capital looking to invest in the biotech sector.

Business keywords: biotech, clinical research, immunomodulating drugs, autoimmune diseases, multiple sclerosis, rheumatoid arthritis, pharmaceuticals, drug development, clinical trials, immune system disorders, medicine, quality of life, treatment, therapy, clinical phase II program

No funding data available for Cyxone yet.

Cyxone Alternatives & Competitors

View All Alternatives
Cyxone vs
Apitope
Apitope Belgium

Develops drugs for treatments of allergic diseases

Series B
1 employees
Biotechnology, Health Care
Cyxone vs
SetPoint Medical
SetPoint Medical United States

Regulating Inflammation - through the nervous system

Venture round
74 employees
Biotechnology, Health Care
Cyxone vs
Synta Pharmaceuticals
Synta Pharmaceuticals

Innovating patient care with advanced small molecule therapies for severe medical conditions, includ...

Post-IPO Equity
Biotechnology, Health Care
View all alternatives

FAQ About Cyxone

Life-changing treatments for disorders of the immune system
Cyxone was founded in 2015.
Cyxone is headquartered in Sweden.
Cyxone operates in Biotechnology and Health Care. Its work centres on biotech, clinical research, immunomodulating drugs and autoimmune diseases.
Cyxone has approximately 11 employees.
Top alternatives and competitors to Cyxone include Apitope, SetPoint Medical, Synta Pharmaceuticals, Tridek-One, Q32 Bio Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cyxone and Apitope are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cyxone, https://bouncewatch.com/company/cyxone, updated 29 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes